An association between glycine and insulin levels is observed in patients with pulmonary tuberculosis and type 2 diabetes

2020 ◽  
Vol 39 (10) ◽  
pp. 3019-3023
Author(s):  
Mariela Zenil-Vega ◽  
Eduarda Cerón ◽  
Guadalupe López-Bello ◽  
Julia Moreno ◽  
Eliuth Juárez-Cruz ◽  
...  
2013 ◽  
Vol 17 (9) ◽  
pp. 670 ◽  
Author(s):  
Sandeep Chaudhary ◽  
Anubhav Thukral ◽  
Shalbha Tiwari ◽  
DaliparthyD Pratyush ◽  
SuryaKumar Singh

2020 ◽  
Vol 45 (4) ◽  
pp. 397-404
Author(s):  
Tugba Gurpinar Çavuşoğlu ◽  
Ertan Darıverenli ◽  
Kamil Vural ◽  
Nuran Ekerbicer ◽  
Cevval Ulman ◽  
...  

AbstractObjectivesType 2 diabetes is a common metabolic disease and anxiety disorders are very common among diabetics. Buspirone is used in the treatment of anxiety, also having blood glucose-lowering effects. The aim of the study was to investigate the effects of buspirone on the glucose and lipid metabolism as well as vascular function in type 2 diabetic rats.MethodsA type 2-diabetic model was induced through a high-fat diet for eight weeks followed by the administration of low-dose streptozotocin (35 mg/kg, intraperitoneal) in rats. Buspirone was given at two different doses (1.5 mg/kg/d and 5 mg/kg/d) and combined with metformin (300 mg/kg/d). The fasting glucose and insulin levels, lipid profile were analyzed, and vascular response measured from the thoracic aorta was also evaluated.ResultsBoth doses of buspirone caused a significant improvement in fasting blood glucose levels. In particular, the buspirone treatment, combined with metformin, improved endothelial dysfunction and was found to be correlated with decreased nitrate/nitrite levels.ConclusionsBuspirone may be effective in the treatment of type 2 diabetes, either alone or in combination with other treatments, particularly in terms of endothelial dysfunction, inflammation and impaired blood glucose, and insulin levels.


2011 ◽  
Vol 5 (2) ◽  
pp. 85-89 ◽  
Author(s):  
Sunil Kumar Kota ◽  
Sruti Jammula ◽  
Siva Krishna Kota ◽  
Prabhas Ranjan Tripathy ◽  
Sandip Panda ◽  
...  

2005 ◽  
Vol 2 (4) ◽  
pp. 208-208 ◽  
Author(s):  
Demosthenes B. Panagiotakos ◽  
Natalia Tzima ◽  
Christos Pitsavos ◽  
Christina Chrysohoou ◽  
Emilia Papakonstantinou ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Theerawut Klangjareonchai ◽  
Chulaporn Roongpisuthipong

Objective. To determine the effects ofTinospora crispaon serum glucose and insulin levels in healthy subjects and patients with type 2 diabetes mellitus.Method. Serum from 10 healthy subjects and 10 diabetic participants, who had fasted overnight, were obtained every 30–60 minutes during the 3 hours of continued fasting and during the 3 hours after ingestion of 75 g of glucose with or without ingestion of 125 or 250 g ofTinospora crispadry powder capsule. Glucose and Insulin levels were analyzed and the areas under the curve for mean serum glucose and insulin levels were calculated.Result. The areas under the curve of mean serum glucose and insulin levels in both healthy and diabetic participants were not significantly different between with or withoutTinospora crispadry powder capsule. In diabetic participants the area under the curve of glucose was slightly lesser when 250 mg ofTinospora crispawas ingested, but not reaching statistical significance (478 and 444 mg min/ml, resp.,P=0.57).Conclusion. The results suggest thatTinospora crispaingestion cannot affect serum glucose and insulin levels in healthy subjects or patients with type 2 diabetes mellitus.


Tuberculosis ◽  
2018 ◽  
Vol 111 ◽  
pp. 114-120 ◽  
Author(s):  
Roberto Sánchez-Jiménez ◽  
Eduarda Cerón ◽  
Demetrio Bernal-Alcántara ◽  
Manuel Castillejos-López ◽  
Eva Gonzalez-Trujano ◽  
...  

2004 ◽  
Vol 89 (5) ◽  
pp. 2078-2084 ◽  
Author(s):  
Bo Ahrén ◽  
Mona Landin-Olsson ◽  
Per-Anders Jansson ◽  
Maria Svensson ◽  
David Holmes ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document